Compass Net Tangible Assets vs Total Assets Analysis

CMPX Stock  USD 1.99  0.11  5.24%   
Compass Therapeutics financial indicator trend analysis is way more than just evaluating Compass Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Compass Therapeutics is a good investment. Please check the relationship between Compass Therapeutics Net Tangible Assets and its Total Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compass Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more information on how to buy Compass Stock please use our How to Invest in Compass Therapeutics guide.

Net Tangible Assets vs Total Assets

JavaScript chart by amCharts 3.21.1520162018202020222024-120M-100M-80M-60M-40M-20M020M40M60M80M100M120M140M160M180M200M220M 30M40M50M60M70M80M90M100M110M120M130M140M150M160M170M180M190M200M
JavaScript chart by amCharts 3.21.15Net Tangible Assetstotal: 429MTotal Assetstotal: 1.2B

Net Tangible Assets vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Compass Therapeutics Net Tangible Assets account and Total Assets. At this time, the significance of the direction appears to have very strong relationship.
Net Tangible AssetsTotal AssetsDiversified AwayNet Tangible AssetsTotal AssetsDiversified Away100%
The correlation between Compass Therapeutics' Net Tangible Assets and Total Assets is 0.89. Overlapping area represents the amount of variation of Net Tangible Assets that can explain the historical movement of Total Assets in the same time period over historical financial statements of Compass Therapeutics, assuming nothing else is changed. The correlation between historical values of Compass Therapeutics' Net Tangible Assets and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Tangible Assets of Compass Therapeutics are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Net Tangible Assets i.e., Compass Therapeutics' Net Tangible Assets and Total Assets go up and down completely randomly.

Correlation Coefficient

0.89
Relationship DirectionPositive 
Relationship StrengthStrong

Net Tangible Assets

The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.

Total Assets

Total assets refers to the total amount of Compass Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Compass Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Compass Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Compass Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compass Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more information on how to buy Compass Stock please use our How to Invest in Compass Therapeutics guide.Tax Provision is expected to grow at the current pace this year, whereas Selling General Administrative is likely to drop slightly above 13.5 M in 2025.
 2022 2023 2024 2025 (projected)
Depreciation And Amortization1.9M1.9M1.7M1.7M
Interest Income2.4M7.9M7.3M7.7M

Compass Therapeutics fundamental ratios Correlations

-0.880.260.620.930.890.110.6-0.19-0.830.680.10.110.21-0.61-0.770.98-0.810.82-0.790.750.9-0.790.930.860.72
-0.880.11-0.51-0.96-1.00.09-0.790.040.98-0.540.010.08-0.180.490.95-0.90.94-0.820.95-0.71-0.970.95-0.96-0.77-0.89
0.260.110.510.1-0.10.26-0.1-0.660.26-0.130.590.23-0.19-0.380.090.150.04-0.240.060.21-0.040.080.10.12-0.1
0.62-0.510.510.590.53-0.130.5-0.04-0.450.23-0.04-0.13-0.24-0.22-0.550.54-0.50.29-0.540.810.49-0.520.590.330.5
0.93-0.960.10.590.96-0.130.8-0.17-0.890.550.08-0.130.15-0.48-0.940.93-0.950.76-0.960.750.98-0.951.00.740.9
0.89-1.0-0.10.530.96-0.070.76-0.04-0.970.55-0.01-0.060.23-0.47-0.950.9-0.950.81-0.950.740.96-0.950.960.770.88
0.110.090.26-0.13-0.13-0.07-0.34-0.330.03-0.120.451.00.56-0.570.290.180.220.110.290.07-0.060.29-0.140.52-0.27
0.6-0.79-0.10.50.80.76-0.340.02-0.780.19-0.1-0.33-0.21-0.27-0.880.65-0.750.59-0.850.60.83-0.850.80.490.97
-0.190.04-0.66-0.04-0.17-0.04-0.330.02-0.10.36-0.98-0.310.00.670.08-0.130.160.260.110.1-0.060.11-0.17-0.23-0.04
-0.830.980.26-0.45-0.89-0.970.03-0.78-0.1-0.540.130.02-0.220.460.91-0.870.87-0.870.89-0.69-0.940.9-0.89-0.78-0.87
0.68-0.54-0.130.230.550.55-0.120.190.36-0.54-0.46-0.140.25-0.06-0.370.65-0.450.79-0.410.410.56-0.410.550.470.31
0.10.010.59-0.040.08-0.010.45-0.1-0.980.13-0.460.440.1-0.670.00.06-0.09-0.3-0.03-0.14-0.01-0.030.080.23-0.03
0.110.080.23-0.13-0.13-0.061.0-0.33-0.310.02-0.140.440.59-0.550.280.180.210.110.280.08-0.050.27-0.130.52-0.25
0.21-0.18-0.19-0.240.150.230.56-0.210.0-0.220.250.10.59-0.08-0.040.33-0.230.32-0.090.280.22-0.10.150.440.01
-0.610.49-0.38-0.22-0.48-0.47-0.57-0.270.670.46-0.06-0.67-0.55-0.080.35-0.590.36-0.390.35-0.2-0.470.35-0.48-0.78-0.32
-0.770.950.09-0.55-0.94-0.950.29-0.880.080.91-0.370.00.28-0.040.35-0.790.96-0.651.0-0.7-0.931.0-0.94-0.59-0.96
0.98-0.90.150.540.930.90.180.65-0.13-0.870.650.060.180.33-0.59-0.79-0.820.88-0.80.780.94-0.80.930.910.77
-0.810.940.04-0.5-0.95-0.950.22-0.750.160.87-0.45-0.090.21-0.230.360.96-0.82-0.640.98-0.7-0.920.98-0.95-0.61-0.88
0.82-0.82-0.240.290.760.810.110.590.26-0.870.79-0.30.110.32-0.39-0.650.88-0.64-0.650.610.85-0.650.760.830.67
-0.790.950.06-0.54-0.96-0.950.29-0.850.110.89-0.41-0.030.28-0.090.351.0-0.80.98-0.65-0.7-0.931.0-0.96-0.59-0.94
0.75-0.710.210.810.750.740.070.60.1-0.690.41-0.140.080.28-0.2-0.70.78-0.70.61-0.70.75-0.690.760.620.7
0.9-0.97-0.040.490.980.96-0.060.83-0.06-0.940.56-0.01-0.050.22-0.47-0.930.94-0.920.85-0.930.75-0.930.970.80.93
-0.790.950.08-0.52-0.95-0.950.29-0.850.110.9-0.41-0.030.27-0.10.351.0-0.80.98-0.651.0-0.69-0.93-0.95-0.59-0.94
0.93-0.960.10.591.00.96-0.140.8-0.17-0.890.550.08-0.130.15-0.48-0.940.93-0.950.76-0.960.760.97-0.950.740.9
0.86-0.770.120.330.740.770.520.49-0.23-0.780.470.230.520.44-0.78-0.590.91-0.610.83-0.590.620.8-0.590.740.6
0.72-0.89-0.10.50.90.88-0.270.97-0.04-0.870.31-0.03-0.250.01-0.32-0.960.77-0.880.67-0.940.70.93-0.940.90.6
Click cells to compare fundamentals

Compass Therapeutics Account Relationship Matchups

Compass Therapeutics fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets51.9M153.8M199.6M156.9M140.4M125.3M
Short Long Term Debt Total9.3M4.0M2.9M1.7M1.6M1.5M
Other Current Liab510K7.9M8.3M(1.6M)(1.8M)(1.7M)
Total Current Liabilities10.1M10.6M16.2M7.8M8.9M11.3M
Total Stockholder Equity39.9M140.1M181.6M148.5M125.2M67.9M
Net Tangible Assets(118.6M)39.9M140.1M181.6M208.9M219.3M
Property Plant And Equipment Net1.1M6.3M4.5M2.7M7.1M4.9M
Net Debt(37.7M)(140.5M)(32.0M)(22.5M)(20.2M)(21.3M)
Retained Earnings(151.4M)(233.6M)(272.8M)(315.3M)(364.7M)(346.4M)
Accounts Payable1.1M867K3.4M4.1M2.2M2.2M
Cash47.1M144.5M34.9M24.2M43.5M43.1M
Non Current Assets Total1.7M6.7M4.9M3.0M7.7M5.3M
Other Assets392K583K0.0320K288K267.5K
Cash And Short Term Investments47.1M144.5M186.6M152.5M175.3M112.5M
Common Stock Total Equity3.3M5K10K13K11.7K11.1K
Common Stock Shares Outstanding30.8M62.9M105.2M127.0M127.7M87.6M
Liabilities And Stockholders Equity51.9M153.8M199.6M156.9M180.4M120.5M
Non Current Liabilities Total1.9M3.0M1.8M536.0K6.3M6.0M
Other Current Assets3.1M2.6M8.2M1.4M6.0M3.7M
Other Stockholder Equity191.3M373.7M454.7M463.8M533.4M273.3M
Total Liab12.0M13.7M18.0M8.3M15.2M14.4M
Net Invested Capital49.3M140.1M181.6M148.5M125.2M74.0M
Property Plant And Equipment Gross1.1M11.4M10.1M8.9M13.4M8.5M
Total Current Assets50.2M147.1M194.8M153.9M132.8M120.0M
Capital Stock3.3M5K10K13K11.7K11.1K
Net Working Capital40.1M136.5M178.6M146.1M123.9M108.7M
Short Term Debt7.5M989K1.1M1.2M1.1M1.0M
Common Stock3.3M5K10K13K11.7K11.1K
Property Plant Equipment3.8M1.1M6.3M1.6M1.4M1.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Compass Stock Analysis

When running Compass Therapeutics' price analysis, check to measure Compass Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Therapeutics is operating at the current time. Most of Compass Therapeutics' value examination focuses on studying past and present price action to predict the probability of Compass Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Therapeutics' price. Additionally, you may evaluate how the addition of Compass Therapeutics to your portfolios can decrease your overall portfolio volatility.

Discover investing ideas

Utilize additional investing modules

News Freq…Investor S…